Back to top

Image: Bigstock

Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

Read MoreHide Full Article

Pfizer (PFE - Free Report) closed at $35.86 in the latest trading session, marking a -1.05% move from the prior day. This move lagged the S&P 500's daily gain of 0.98%. At the same time, the Dow added 0.99%, and the tech-heavy Nasdaq gained 0.5%.

Wall Street will be looking for positivity from PFE as it approaches its next earnings report date. This is expected to be February 2, 2021. In that report, analysts expect PFE to post earnings of $0.48 per share. This would mark a year-over-year decline of 12.73%. Meanwhile, our latest consensus estimate is calling for revenue of $12.25 billion, down 3.46% from the prior-year quarter.

It is also important to note the recent changes to analyst estimates for PFE. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 4.65% lower. PFE is currently a Zacks Rank #3 (Hold).

Valuation is also important, so investors should note that PFE has a Forward P/E ratio of 11.43 right now. For comparison, its industry has an average Forward P/E of 13.96, which means PFE is trading at a discount to the group.

Investors should also note that PFE has a PEG ratio of 2.34 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Large Cap Pharmaceuticals was holding an average PEG ratio of 2.08 at yesterday's closing price.

The Large Cap Pharmaceuticals industry is part of the Medical sector. This group has a Zacks Industry Rank of 196, putting it in the bottom 24% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow PFE in the coming trading sessions, be sure to utilize Zacks.com.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Pfizer Inc. (PFE) - free report >>

Published in